Cytox: Ian Gilham
Cytox has appointed Ian Gilham its chairman of the board. He was CEO of Axis-Shield until Alere acquired the company in 2011. He also held positions at Amersham International, Abbott Laboratories, and GlaxoSmithKline. Gilham is currently non-executive chairman of Horizon Discovery, Genedrive, and Biosurfit and previously was chairman of Multiplicom and Elucigene. Oxford, UK-based Cytox develops noninvasive risk assessment and patient stratification tools for Alzheimer's disease and dementia.